Good news for patients with #DLBCL Diffuse large B-cell #lymphoma that #epcoritamab has received a positive funding recommendation from the PBAC in Australia. #lymsm 2L Axi-Cel this week, bispecifics in the 3L soon, it seems. Good news on a Friday. #lymsm
buff.ly
Pharmaceutical Benefits Scheme (PBS) | PBAC Outcomes
See also